<- Go Home
Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Market Cap
BRL 7.9B
Volume
3.3M
Cash and Equivalents
BRL 9.7M
EBITDA
BRL 1.9B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
BRL 2.3B
Profit Margin
26.61%
52 Week High
BRL 18.10
52 Week Low
BRL 12.48
Dividend
8.28%
Price / Book Value
1.53
Price / Earnings
12.54
Price / Tangible Book Value
-10.99
Enterprise Value
BRL 11.2B
Enterprise Value / EBITDA
5.13
Operating Income
BRL 1.3B
Return on Equity
11.67%
Return on Assets
6.05
Cash and Short Term Investments
BRL 2.2B
Debt
BRL 5.4B
Equity
BRL 5.3B
Revenue
BRL 8.5B
Unlevered FCF
BRL 1.1B
Sector
Health Care Providers and Services
Category
N/A